I
Scientific Sessions (updated April 16, 2013)
PLENARY SESSIONS
Plenary I
  • Treating Hepatitis B in 2012
    C.L. Lai (China)
Plenary II
  • Finding a Cure for HIV: The Need for Science, Collaboration and Advocacy
    S. Lewin (Australia)
Plenary III
  • Infection Control: Worldwide Perspectives
    D. Pittet (Switzerland)
Plenary IV
  • The Future of Dengue
    D. Gubler (Singapore)
Plenary V
  • Vaccines for Cholera, Shigellosis and Typhoid
    J. Clemens (Republic of Korea)
Plenary VI
  • Confronting TB in the Era of HIV
    S. Lawn (South Africa)


SYMPOSIA
Acute Febrile Illness in the Tropics
  • Acute Febrile Illness in Africa
    O. Mediannikov (Senegal)
  • Acute Febrile Illness: Epidemiology vs Clinical Judgment
     R. Premaratna (Sri Lanka)
  • Laboratory Diagnosis of Acute Febrile Illness: Where Are We Now?
    C.C. Chao (USA)
  • Strategies for Diagnosis and Treatment of Acute Febrile Illness in Asia
    Y. Suputtamongkol (Thailand)
Typhoid Fever
  • Typhoid Epidemiology
    L. Ochiai (South Korea)
  • Typhoid Diagnostics
    S. Baker (Vietnam)
  • Typhoid Treatment and MDR Typhoid
    TBD
  • Typhoid Vaccine Landscape
    A. Pollard (United Kingdom)
Hepatitis C: State of the Art
  • Hepatitis C: Asia-Pacific Perspective
    T. Piratvisuth (Thailand)
  • Treatment of Hepatitis C in 2012
    J. Koirala (USA)
  • Management of Hepatitis C in HIV-Coinfected Patients
    J. Rockstroh (Germany)
  • Epidemiology of Hepatitis C Virus- Genotypes 1 Through 6 in Asia and the World
    Y. Poovorawan (Thailand)
Delivering HIV Treatment and Care in Limited Resource Settings
  • Delivering HIV Treatment & Care in Resource Limited Settings - Therapeutic Mobile Units
    F.X. Mbopi Keou (Cameroon)
  • New Diagnostic Tools for Monitoring Antiretroviral Therapy in Resource Limited Settings
    S. Crowe (Australia)
  • Management of Antiretroviral-Therapy Failure in Resource-Limited Settings
    K. Ruxrungtham (Thailand)
  • HIV Drug Resistance Testing in Asia – Is it Time?
    S. Sungkanuparph (Thailand)
Getting to Zero: Antiretrovirals as a Tool for Prevention
  • State of the Science: Antiretroviral Treatment for Prevention
    B. Hirschel (Switzerland)
  • Treatment 2.0
    M. Kato (Viet Nam)
  • State of the Science: HIV Pre Exposure Prophylaxis (PrEP)
    S. Chariyalertsak (Thailand)
  • Implementing PrEP – Are We Ready?
    J. Ananworanich (Thailand)
Update on Hepatitis B
  • Epidemiology and Natural Course of Chronic Viral hepatitis B in Asia
    S. Thongsawat (Thailand)
  • Updates on the Pathogenesis of Hepatitis B
    J. Cheng (China)
  • Occult Hepatitis B and Its Clinical Relevance
    TBD
  • Updates on Early Diagnosis and Management of Hepatocellular Carcinoma in HBV
    P. Komolmit (Thailand)
The Challenge of Pediatric Tuberculosis in Low and Middle Income Countries
  • Epidemiology, Clinical Manifestations, and Diagnostic Challenges of Pediatric TB
    C. Sreeramareddy (Malaysia)
  • The Impact of Drug Resistance and HIV-infection on the Problem of Pediatric TB
    T. Phe (Cambodia)
  • Update on Laboratory Diagnosis of Pediatric TB: New and More Rapid Methods
    C. Mukhopadhyay (India)
  • Programmatic Barriers, Current Treatment and Control Strategies for Pediatric TB
    M. Rahman (Bangladesh)
Infectious Diseases in Marginalized Populations
  • Infectious Diseases Among Refugees in Beirut
    I. Beldjebel (Lebanon)
  • Infectious Diseases in Orphanages in South-east Asia
    J. Benca (Cambodia)
  • Infections in Homeless
    V. Krcmery (Slovakia)
  • Infectious Diseases of Street Children in Nairobi
    L. Alumbasi Timona (Kenya)
Infectious Issues in Transplantation
  • The Pre-Transplant Evaluation
    N. Smitasin (Singapore)
  • Donor Derived Infections
    G. Reid (USA)
  • State of the Art: Transplantation in HIV Infected Individuals
    M. Brito (USA)
  • Common Respiratory Viral Infections
    L. Kaiser (Switzerland)
Initiatives for the Control of Infectious Diseases
  • Novel Resources to Fund Health Enterprises and Develop New Drugs
    F. Waldvogel (Switzerland)
  • Facilitating Clinical Research for Global Health Needs
    J. Farrar (Vietnam)
  • Infectious Diseases Surveillance and Alert Systems
    L. Madoff (USA)
Innate immunity and infectious diseases
  • Innate Immune Recognition and Response to Pathogens
    S. Akira (Japan)
  • Malaria and Innate Immunity
    D. Golenbock (USA)
  • Stimulation of Macrophage Innate Immunity to Prevent Human Mycobacterial Disease
    O. Stendahl (Sweden)
  • Relationship Between the Innate Immune System and the Acquired Immune System: Implications for Vaccine Development
    K. Rock (USA)
International Perspectives on Infection Control
  • Global Infection Control: A  U.S. Perspective on Health Care Associated Infections
    R. Wenzel (USA)
  • Infection Control to Curb Resistance in Asia
    W.H. Seto (China)
  • Implementing Infection Control in Resource Limited Settings
    G. Mehta (India)
  • Regional Differences Impacting Infection Control Practices
    B. Allegranzi (Switzerland)
Update on Influenza
  • Human and Animal Epidemiology of Influenza in Southeast Asia
    T. Chotpitayasunondh (Thailand)
  • Clinical Features and Pathogenesis of H5N1 Influenza in Humans
    T.T. Hien (Vietnam)
  • Newer Influenza Antivirals and Bbiotherapeutics
    F. Hayden (USA)
  • Seasonal, Pandemic, and Inter-pandemic Vaccines
    L. Jennings (New Zealand)
MRSA: Keeping up with the Evolving Pathogen
  • Transmission Dynamics of MRSA in Asia
    B. Cooper (Thailand)
  • Developing Resistance to Drugs Against MRSA
    I. Gould (UK)
  • Resistance to Agents for MRSA Decolonization and its Clinical Implications
    A. Apisarnthanarak (Thailand)
  • PK/PD Considerations when Treating MRSA
    T. Mazzei (Italy)
Major Drivers of Change in Global Infectious Diseases Epidemiology
  • Urbanization
    L. Loutan (Switzerland)
  • Pilgrimages and Mass Migrations
    Z. Memish (Kingdom of Saudi Arabia)
  • Changing Interfaces with Animals: Emerging Zoonoses
    R. Coker (UK)
Major Vaccine Issues
  • Eradicating Polio
    J. John (India)
  • Is Hepatitis A Vaccination Underutilized?
    R. Dagan (Israel)
  • Vaccination Programs in Southeast Asia
    U. Thisyakom (Thailand)
  • Facing Antivaccine Movements: Myths and Facts about Adverse Events
    K. Powell (USA)
Carbapenem Resistance
  • Overview of Carbapenemase Mediated Resistance
    G. Cornaglia (Italy)
  • Detection of Carbapenemase Resistance
    P. Nordmann (France)
  • The Role of Antimicrobial Stewardship in Curbing Carbapenem
    D. Lye (Singapore)
  • The Role of Infection Control in Curbing Carbapenem Resistance
    A. Apisarnthanarak (Thailand)
NTDs in Asia and Pacific: Progress towards Elimination and Control
  • Neglected Tropical Diseases Targeted for Elimination in South-East Asia- Progress so Far
    A.P. Dash (India)
  • Elimination of Lymphatic Filariasis in Bangladesh - Critical issues
    I. Hafiz (Bangladesh
  • NTD Programmes in the Western Pacific Region - Challenges & Opportunities
    TBD
  • Schistosomiasis Control Programme in China: Towards Elimination
    X. Zhou (China)
Coinfections in HIV
  • The role of Coinfections in HIV Epidemic Trajectory and Positive Prevention
    R. Barnabas (USA)
  • Hepatitis B Coinfection: Implications for Management
    A. Avihingsanon (Thailand)
  • HPV and HIV Coinfection
    N. Phanuphak (Thailand)
  • Syphilis and HIV: Problem and Prevention
    JT. Lau (China)
Antibiotic Stewardship: Different Challenges in Different Countries
  • Singapore
    L.Y. Hsu (Singapore)
  • Taiwan
    P. Hsueh (Taiwan)
  • Japan
    K. Yanagihara (Japan)
  • South Korea
    D.Y. Chung (South Korea)
  • Thailand
    R. Chaiwarith (Thailand)
Pneumococcal Mucosal Infections, Interaction with Other Organisms and Pneumococcal Vaccines
  • Carriage of S. pneumoniae and Related Respiratory Pathogens Post PCV Implementation
    E. Sanders (The Netherlands)
  • Density of Carriage - Can it Predict Pneumonia?
    K. Klugman (USA/South Africa)
  • How do PCVs Affect the Multi-Bacterial Nature of Otitis Media?
    R. Dagan (Israel)
  • Streptococcus pneumoniae and Viruses: Do we Know Everything?
    TBD
Facing the Challenges in Malaria
  • Emerging Drug Resistance
    A. Dondorp (Thailand)
  • Progress Towards Effective Malaria Vaccination
    D. Gray Heppner (USA)
  • A Future Without Malaria?
    Y. Yuthavong (Thailand)
  • Update on Management of Severe Malaria?
    S. Mishra (India)
Fluoroquinolones: CAP, TB and the Importance of Differential Diagnosis
  • Diagnostic Challenges and Interactive Case Histories
    PR Hsueh (Taiwan)
  • Fluoroquinolones: A Role in CAP and TB
    R. Grossman (Canada)
  • Fluoroquinolones in TB: The Future
    S. Gillespie (UK)
Eliminating Visceral Leishmaniasis from the South-East Asia Region: Prospects and Opportunities
  • Elimination of Kala-azar: Where Do We Stand in 2011?
    S.K. Bhattacharya (India)
  • Progress in Treatment of Kala-azar
    S. Rijal (Nepal)
  • Kala-azar Elimination - Monitoring and Evaluation
    M. Rahman (Bangladesh)
Fungal Infections, Near and Far
  • Pythium Insidiosum Infections
    Boonmee Satapathayavongs (Thailand)
  • Penicillium Marneffei Infections
    Khuanchai Supparatpinyo (Thailand)
  • Changing Epidemiology and Treatment Options in Invasive Candida Infections
    T. Gottlieb (Australia)
  • TBD
    TBD
Encephalitis: Panel Discussion and Interactive Case Studies
  • Encephalitis: Panel Discussion and Interactive Case Studies
    TBD
  • Encephalitis: Panel Discussion and Interactive Case Studies
    J. Laothamatas (Thailand)
  • Encephalitis: Panel Discussion and Interactive Case Studies
    T. Hemachudha (Thailand)